Metraipolis › archive › dc_057b04e87b06
Feasibility of Polylactic Acid-Polycaprolactone-Blended Microspheres in Transarterial Embolization Therapy — Europe PMC PMID:42598380
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42598380
- DOI
- 10.1021/acsomega.6c00948
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-18T13:58:50.284Z
- SHA-256 of the archived text
9ae848edf3c2342a28e5d6db2a83e2f64a7650eee3340c3012037e1360d49ad5- Stable URL of this page
https://metraipolis.com/documento/dc_057b04e87b06
How to cite
Feasibility of Polylactic Acid-Polycaprolactone-Blended Microspheres in Transarterial Embolization Therapy — Europe PMC PMID:42598380 — Europe PMC (en), https://europepmc.org/article/MED/42598380 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_057b04e87b06 (Metraipolis archive dc_057b04e87b06, sha256 9ae848edf3c2342a28e5d6db2a83e2f64a7650eee3340c3012037e1360d49ad5)
BibTeX
@misc{dc057b04e87b06,
title = {Feasibility of Polylactic Acid-Polycaprolactone-Blended Microspheres in Transarterial Embolization Therapy — Europe PMC PMID:42598380},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42598380},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_057b04e87b06; sha256 9ae848edf3c2342a28e5d6db2a83e2f64a7650eee3340c3012037e1360d49ad5},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42598380. Agents can read the archived copy with the MCP tool read_document.